Ropheka Pharmacy is preparing to expand into the federal 340B Drug Pricing Program through strategic partnerships with eligible covered entities.
While we are not currently contracted under the 340B program, we are intentionally building the operational, compliance, and reporting infrastructure required to support high-quality, audit-ready 340B pharmacy services. Our approach prioritizes transparency, patient care, and long-term sustainability.
We are taking a phased and intentional approach to ensure that every aspect of our future 340B offering meets regulatory standards and aligns with our mission of excellence in care.
The 340B Drug Pricing Program enables eligible healthcare organizations — known as covered entities — to purchase outpatient medications at reduced prices.
These savings allow organizations to stretch limited resources and reinvest in expanded services, improved access to care, and better patient outcomes.
We welcome early conversations with organizations that are: